Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Secaucus › NPI 1710491253
Hospital

Njmhmc, LLC

Njmhmc, LLC was paid $22.78M by Medicaid between Jan 2018 and Nov 2024, across 226 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.

33Billing provider infoNJMHMC, LLC
SECAUCUS, NJ 07094
33aNPI1710491253assigned 11/20/2017
28Total paid$22.78M
24GClaims356,056
24DCodes billed226
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#54 of 93
Median peer was paid$30.60M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,933$2.15M
201947,737$3.70M
202033,505$2.65M
202150,739$3.03M
202263,754$3.46M
202373,717$3.93M
2024incomplete60,671$3.86M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 32% 22,140 20,486 $7.33M
OP710 8.5% 9,354 8,444 $1.94M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 5.1% 1,473 1,354 $1.15M
OP379 4.2% 6,567 6,073 $967K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.1% 3,005 2,811 $929K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.3% 2,924 2,747 $749K
C1776 Joint device (implantable) 3.0% 448 375 $694K
A0429 Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) 2.4% 3,827 3,250 $543K
G0378 Hospital observation service, per hour 2.3% 1,093 632 $521K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.2% 1,078 1,051 $499K
41899 Unlisted procedure, dentoalveolar structures 2.1% 402 374 $471K
64483 2.0% 1,071 1,014 $466K
214 more codes
45380 Colonoscopy, flexible; with biopsy, single or multiple 2.0% 842 $455K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.8% 550 $416K
20553 1.2% 1,549 $269K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.2% 11,080 $268K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.2% 924 $266K
64450 1.2% 1,365 $264K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 1,555 $249K
70450 Computed tomography, head or brain; without contrast material <1% 2,598 $221K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,104 $217K
93458 <1% 163 $207K
OP278 <1% 1,030 $207K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 245 $193K
76000 <1% 3,918 $178K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,229 $147K
A4641 Radiopharmaceutical, diagnostic, not otherwise classified <1% 828 $139K
OP279 <1% 6,016 $136K
27447 <1% 209 $128K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,898 $127K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,388 $125K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 14,088 $110K
72020 <1% 3,168 $106K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,542 $92K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 15,092 $83K
64493 <1% 158 $77K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 44 $76K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 158 $74K
80053 Comprehensive metabolic panel <1% 13,316 $68K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,093 $66K
64494 <1% 149 $60K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 10,394 $60K
93975 <1% 449 $60K
64484 <1% 402 $54K
71046 Radiologic examination, chest; 2 views <1% 2,613 $53K
71045 Radiologic examination, chest; single view <1% 3,445 $51K
64495 <1% 111 $49K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 175 $47K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,821 $44K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 231 $42K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 143 $41K
64635 <1% 48 $37K
A0425 Ground mileage, per statute mile <1% 4,415 $33K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,706 $32K
OP259 <1% 23,353 $31K
64451 <1% 385 $31K
86900 <1% 2,456 $30K
95811 <1% 12 $29K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,459 $28K
88342 <1% 800 $27K
97161 <1% 624 $25K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 801 $24K
96375 Therapeutic injection; each additional sequential IV push <1% 2,478 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 787 $23K
73221 <1% 76 $23K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,238 $23K
88313 <1% 798 $19K
84443 Thyroid stimulating hormone (TSH) <1% 1,491 $19K
64636 <1% 51 $18K
80061 Lipid panel <1% 1,225 $18K
73564 <1% 802 $17K
84484 <1% 4,333 $15K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 202 $15K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 463 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 767 $14K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,295 $14K
84703 <1% 10,119 $13K
85610 <1% 6,056 $13K
73700 <1% 166 $13K
72110 <1% 455 $13K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 400 $12K
85730 <1% 5,130 $11K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 529 $11K
73565 <1% 562 $11K
J2785 Injection, regadenoson, 0.1 mg <1% 450 $10K
J2704 Injection, propofol, 10 mg <1% 4,403 $10K
81001 <1% 9,818 $10K
86769 <1% 162 $9K
97162 <1% 254 $9K
87070 <1% 2,663 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,135 $8K
87802 <1% 2,570 $8K
82948 <1% 4,168 $8K
86850 <1% 2,369 $8K
73610 <1% 461 $8K
62321 <1% 27 $7K
86780 <1% 584 $7K
83690 <1% 3,607 $7K
86803 <1% 441 $7K
72125 Computed tomography, cervical spine; without contrast material <1% 278 $7K
87400 <1% 3,982 $7K
77067 Screening mammography, bilateral, including computer-aided detection <1% 71 $7K
62323 <1% 12 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,243 $6K
97014 <1% 659 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 1,737 $6K
86901 <1% 2,509 $5K
J3490 Unclassified drugs <1% 2,263 $5K
73630 <1% 418 $5K
87340 <1% 480 $5K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,995 $5K
73030 <1% 337 $5K
73502 <1% 255 $4K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 860 $4K
36415 Collection of venous blood by venipuncture <1% 4,049 $4K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,621 $4K
L2280 Addition to lower extremity, molded inner boot <1% 947 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,124 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 44 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 1,108 $3K
76830 Ultrasound, transvaginal <1% 65 $3K
84702 <1% 657 $3K
76641 <1% 52 $3K
73560 <1% 382 $3K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 160 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,006 $2K
88304 <1% 303 $2K
87040 <1% 295 $2K
71250 <1% 26 $2K
82150 <1% 434 $2K
86756 <1% 299 $2K
71275 Computed tomographic angiography, chest, with contrast material <1% 14 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 84 $2K
64418 <1% 13 $2K
64405 <1% 13 $2K
OP250 <1% 2,451 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 30 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,696 $2K
73130 <1% 121 $2K
OP270 <1% 267 $2K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 160 $2K
83605 <1% 443 $1K
87420 <1% 500 $1K
A4649 Surgical supply; miscellaneous <1% 544 $1K
85378 <1% 852 $1K
72131 <1% 13 $1K
87270 <1% 145 $1K
86706 <1% 122 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,129 $1K
0011A <1% 42 $1K
76770 <1% 12 $1K
84439 <1% 148 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,956 $1K
A4930 Gloves, sterile, per pair <1% 1,249 $1K
87081 <1% 155 $1K
82550 <1% 361 $994.66
97535 Self-care/home management training, each 15 minutes <1% 456 $964.51
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 424 $945.13
80305 <1% 72 $888.79
83735 <1% 810 $868.60
J3370 Injection, vancomycin hcl, 500 mg <1% 718 $811.35
76536 <1% 15 $807.31
76870 <1% 12 $804.44
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,491 $801.79
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 13 $739.62
80320 <1% 194 $723.64
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,002 $672.16
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 31 $669.73
87641 <1% 166 $609.56
86704 <1% 42 $564.01
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) <1% 16 $479.51
86762 <1% 72 $428.52
J1010 Injection, methylprednisolone acetate, 1 mg <1% 629 $421.32
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 92 $399.24
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 456 $359.57
82607 <1% 36 $335.92
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 197 $324.63
86787 <1% 25 $286.40
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 337 $261.30
84153 <1% 12 $237.50
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 33 $235.43
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 116 $214.81
82728 <1% 17 $207.21
84481 <1% 17 $199.20
C9113 Injection, pantoprazole sodium, per vial <1% 304 $198.09
82746 <1% 17 $176.27
96361 Intravenous infusion, hydration; each additional hour <1% 72 $169.76
88311 <1% 75 $151.53
87186 <1% 14 $150.91
86701 <1% 25 $144.00
90714 <1% 37 $141.42
87077 <1% 14 $131.65
C9290 Injection, bupivacaine liposome, 1 mg <1% 221 $122.09
83540 <1% 31 $113.00
J7643 Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram <1% 116 $109.91
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 96 $109.87
97164 <1% 43 $106.14
84100 <1% 102 $90.75
82043 <1% 51 $84.13
83880 <1% 12 $77.02
88300 <1% 15 $64.10
J7120 Ringers lactate infusion, up to 1000 cc <1% 159 $60.47
J7060 5% dextrose/water (500 ml = 1 unit) <1% 216 $52.90
S0028 Injection, famotidine, 20 mg <1% 324 $48.37
83550 <1% 17 $47.49
82950 <1% 14 $46.05
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 246 $45.94
86140 <1% 26 $43.41
A4600 Sleeve for intermittent limb compression device, replacement only, each <1% 51 $39.12
J1040 Injection, methylprednisolone acetate, 80 mg <1% 16 $33.84
84436 <1% 15 $33.51
J1170 Injection, hydromorphone, up to 4 mg <1% 95 $31.89
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 267 $21.65
72170 <1% 27 $21.45
OP290 <1% 148 $20.87
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 86 $19.48
85651 <1% 12 $18.25
E0769 Electrical stimulation or electromagnetic wound treatment device, not otherwise classified <1% 30 $16.21
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 27 $16.00
J1644 Injection, heparin sodium, per 1000 units <1% 27 $8.35
J3260 Injection, tobramycin sulfate, up to 80 mg <1% 93 $4.00
91301 <1% 43 $2.00
20985 0% 46 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 0% 48 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 13 $0.00
99152 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKARSOS, FELICIA (CEO)